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Total Coronary Artery Calcium Score Remains Preferred
Metric to Reﬁne Risk Prediction in Nearly All Patients*
Sandeep Bansal, MD, MPH, Roger S. Blumenthal, MD, FACC
Baltimore, MarylandCardiovascular risk prediction remains an imperfect
science. Current risk prediction models rely on
demographic information, medical history, and lab-
oratory tests. Scoring tools such as the Framingham
Risk Score (1) help clinicians to stratify patients
into low-, intermediate-, and high-risk categories
of developing coronary heart disease (CHD). Its
limitations include its generalizability to underrep-
resented minorities and its relatively short 10-year
perspective in defining risk (2). Moreover, relatively
few women qualify for aspirin or statin therapy
before age 65 years (3,4).
Although the Framingham Risk Score is the
standard tool for guiding the aggressiveness with
which pharmacological and lifestyle interventions
are recommended, most clinicians would like to
know which “low-risk” patients actually have ad-
vanced subclinical atherosclerosis for their age and
See page 61
gender and which “low-risk” subjects actually have
no or minimal plaque burden. There is great inter-
est in quantifying atherosclerosis to determine
whether to initiate aspirin and statin therapy rather
than waiting until the patient has an event or
qualifies for these treatments by reaching the cur-
rently designated threshold of a 10% risk of a hard
event (heart attack or CHD death) over the next
decade.
Total coronary artery calcium scores (CACS) are
strongly associated with total atherosclerotic plaque
*Editorials published in the JACC: Cardiovascular Imaging reflect the
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(5,6). Clear evidence regarding the prognostic
strength of CACS in predicting CHD events has
now emerged in multiple prospective studies that
have been summarized in recent American Heart
Association (AHA) and American College of Car-
diology Foundation (ACCF) statements (6,7). As
compared with those without any coronary calcifi-
cation, a recent meta-analysis found relative risk
ratios for a CACS of 100 to 400, 401 to 1,000, and
1,000 of 4.3 (95% confidence interval [CI] 3.5 to
5.2, p  0.0001), 7.2 (95% CI 5.2 to 9.9, p 
0.0001), and 10.8 (95% CI 4.2 to 27.7, p 
0.0001), respectively (8). Moreover, subjects with
no CAC had a very low rate (approximately 0.4%)
of a hard event over 3 to 5 years of observation.
The latest AHA and ACCF statements indicate
that a CAC scan can be a useful tool in refining risk
prediction in intermediate-risk adults (6,7). Inter-
mediate risk is currently defined by national guide-
lines as a 10-year risk of 10% to 20% of a hard event
(6–8), but it was previously classified by the 2003
ACCF Bethesda Conference on Atherosclerosis
Imaging as a 6% to 20% risk of a hard event (9). In
our view, this expanded 6% to 20% category is more
useful when trying to more accurately risk stratify
persons with a family history of premature CHD or
in people with several components of the metabolic
syndrome, because the Framingham Risk Score
does not take into account family history, triglycer-
ide levels, or waist circumference (3).
Previous studies have primarily used total CACS to
predict coronary risk (10,11). The total calcium score
correlates with the amount of coronary atherosclerosis
and provides an estimate of an individual’s total plaque
burden. However, further refinement of coronary risk
might theoretically be obtained by more closely exam-
ining the number and extent of calcified lesions within
the coronary tree.
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71In this issue of JACC: Cardiovascular Imaging,
illiams et al. (12) report the findings of their
tudy addressing this question. They sought to
etermine whether additional information on the
umber and location of calcified plaques adds to the
trong prognostic value of total CACS. They ana-
yzed nearly 15,000 asymptomatic individuals free
f coronary artery disease, but with 1 cardiac risk
actor, who were referred for CACS.
The total number of calcified lesions was strongly
ssociated with mortality. However, this risk
eemed to be explained by the total burden of CAC
ecause when analyses were stratified by categories
f total CACS, the number of lesions no longer
eemed to provide significant prognostic informa-
ion. One exception was in the small subgroup of
ubjects with elevated CACS (400) that was
oncentrated in 1 or 2 lesions, in which the relative
isk of mortality was particularly high. The investi-
ators also report associations between lesion count
n the left main artery and mortality and that a high
ACS in the left main and left anterior descending
rteries is associated with increased risk of mortal-
ty, whereas a high CACS in the circumflex and
ight coronary arteries is not.
Their conclusions should be interpreted with
everal caveats. The multivariable models adjust for
he traditional risk factors of age, gender, smoking,
iabetes, hypertension, and hyperlipidemia, but not
or a family history of premature CHD. They also
sed the dichotomized categories of hypertension
nd hyperlipidemia rather than the individual com-
onents of systolic and diastolic blood pressure and
otal and high-density lipoprotein cholesterol, all of
hich may be somewhat stronger determinants of
AC.
Second, the investigators do not present the
esults of some of their subgroup analyses with CIs.
ne positive finding in the study was that the
umber of lesions predicted mortality independentcation Program Panel III guidelines.
J Am Coll Cardiol 2005;46:1931–6. Coronary arteryocally located on 1 or 2 lesions. The investigators
o not provide the number of subjects who fall into
his unusual category, which we might expect to be
ery small. Similarly, a large number of lesions in
he left main artery were associated with increased
ortality. However, 1% of subjects had even 3
eft main artery lesions, making any extrapolation to
6 lesions less stable risk estimates. Mohlenkamp
t al. (13) previously reported that calcium scores
1,000 in left main artery disease were the only
ndependent predictor of hard events (hazard ratio
.5, 95% CI 1.1 to 17.8).
The current study may have had additional power
o detect the incremental prognostic value of the
umber, location, and extent of coronary lesions if
ata regarding cause of death were available or if
onfatal cardiovascular outcomes had been in-
luded. The failure of the location and number of
alcifications in predicting cardiovascular outcomes
fter accounting for total CACS is not entirely
nexpected. Although total CACS tracks well with
otal plaque burden, there is little correlation be-
ween individual calcifications and luminal stenoses
een on angiography (14).
Our goal should be to target our therapies to
hose who would most benefit from them. As we
mprove the accuracy with which we categorize
atients into risk strata, we will be better equipped
o decide when to promote aggressive lifestyle
hanges and when to institute antiplatelet therapy
r more stringent cholesterol (and perhaps blood
ressure) goals. Future studies may yet improve on
he current metric of total CACS in risk stratifica-
ion, but until then the aggregate value seems to be
he most useful parameter.
eprint requests and correspondence: Dr. Roger S. Blu-
enthal, Johns Hopkins Ciccarone Center for Preven-
ion of Heart Disease, Blalock 524C, The Johns Hopkins
ospital, 600 North Wolfe Street, Baltimore, Marylandf total CACS when the CACS was high and 21287. E-mail: rblument@jhmi.edu.E F E R E N C E S
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